These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

834 related items for PubMed ID: 29856344

  • 1. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
    Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A, V212 Protocol 001 Trial Team.
    Lancet; 2018 May 26; 391(10135):2116-2127. PubMed ID: 29856344
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
    Mullane KM, Morrison VA, Camacho LH, Arvin A, McNeil SA, Durrand J, Campbell B, Su SC, Chan ISF, Parrino J, Kaplan SS, Popmihajlov Z, Annunziato PW, V212 Protocol 011 Trial Team.
    Lancet Infect Dis; 2019 Sep 26; 19(9):1001-1012. PubMed ID: 31399378
    [Abstract] [Full Text] [Related]

  • 3. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
    Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM, ZOE-HSCT Study Group Collaborators.
    JAMA; 2019 Jul 09; 322(2):123-133. PubMed ID: 31287523
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for preventing herpes zoster in older adults.
    de Oliveira Gomes J, Gagliardi AM, Andriolo BN, Torloni MR, Andriolo RB, Puga MEDS, Canteiro Cruz E.
    Cochrane Database Syst Rev; 2023 Oct 02; 10(10):CD008858. PubMed ID: 37781954
    [Abstract] [Full Text] [Related]

  • 5. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM, Andriolo BN, Torloni MR, Soares BG, de Oliveira Gomes J, Andriolo RB, Canteiro Cruz E.
    Cochrane Database Syst Rev; 2019 Nov 07; 2019(11):. PubMed ID: 31696946
    [Abstract] [Full Text] [Related]

  • 6. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT.
    Lancet Infect Dis; 2012 Apr 07; 12(4):290-9. PubMed ID: 22237175
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S, Reddy P, Verma S, Singh C, Redkar S, Mohapatra S, Pandey A, Ranganadin P, Gumashta R, Multani M, Mohammad S, Bhatt P, Kumari L, Sapkal G, Gupta N, Abraham P, Panda S, Prasad S, Bhargava B, Ella K, Vadrevu KM, COVAXIN Study Group.
    Lancet; 2021 Dec 11; 398(10317):2173-2184. PubMed ID: 34774196
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
    Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, Sohn SK, Rodriguez Macías G, Chiou TJ, Quiel D, Aoun M, Navarro Matilla MB, de la Serna J, Milliken S, Murphy J, McNeil SA, Salaun B, Di Paolo E, Campora L, López-Fauqued M, El Idrissi M, Schuind A, Heineman TC, Van den Steen P, Oostvogels L, Zoster-039 study group.
    Lancet Infect Dis; 2019 Sep 11; 19(9):988-1000. PubMed ID: 31399377
    [Abstract] [Full Text] [Related]

  • 9. A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.
    Strezova A, Godeaux O, Aggarwal N, Leroux-Roels G, Lopez-Fauqued M, Van Damme P, Vanden Abeele C, Vastiau I, Heineman TC, Lal H.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6700-6706. PubMed ID: 29079101
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Russo D, Schmitt M, Pilorge S, Stelljes M, Kawakita T, Teal VL, Haber B, Bopp C, Dadwal SS, Badshah C.
    Lancet Haematol; 2024 Feb 04; 11(2):e127-e135. PubMed ID: 38142695
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
    Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barberà J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC, ZOE-70 Study Group.
    N Engl J Med; 2016 Sep 15; 375(11):1019-32. PubMed ID: 27626517
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, ZOE-50 Study Group.
    N Engl J Med; 2015 May 28; 372(22):2087-96. PubMed ID: 25916341
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Zhu F, Huang S, Liu X, Chen Q, Zhuang C, Zhao H, Han J, Jaen AM, Do TH, Peter JG, Dorado AG, Tirador LS, Zabat GMA, Villalobos REM, Gueco GP, Botha LLG, Iglesias Pertuz SP, Tan J, Zhu K, Quan J, Lin H, Huang Y, Jia J, Chu X, Chen J, Chen Y, Zhang T, Su Y, Li C, Ye X, Wu T, Zhang J, Xia N, COVID-19-PRO-003 Study Team.
    Lancet Respir Med; 2023 Dec 28; 11(12):1075-1088. PubMed ID: 37979588
    [Abstract] [Full Text] [Related]

  • 14. Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
    Beals CR, Railkar RA, Schaeffer AK, Levin Y, Kochba E, Meyer BK, Evans RK, Sheldon EA, Lasseter K, Lang N, Weinberg A, Canniff J, Levin MJ.
    Lancet Infect Dis; 2016 Aug 28; 16(8):915-22. PubMed ID: 27061887
    [Abstract] [Full Text] [Related]

  • 15. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM.
    N Engl J Med; 2002 Jul 04; 347(1):26-34. PubMed ID: 12097537
    [Abstract] [Full Text] [Related]

  • 16. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.
    Stadtmauer EA, Sullivan KM, El Idrissi M, Salaun B, Alonso Alonso A, Andreadis C, Anttila VJ, Bloor AJ, Broady R, Cellini C, Cuneo A, Dagnew AF, Di Paolo E, Eom H, González-Rodríguez AP, Grigg A, Guenther A, Heineman TC, Jarque I, Kwak JY, Lucchesi A, Oostvogels L, Polo Zarzuela M, Schuind AE, Shea TC, Sinisalo UM, Vural F, Yáñez San Segundo L, Zachée P, Bastidas A.
    Hum Vaccin Immunother; 2021 Nov 02; 17(11):4144-4154. PubMed ID: 34406911
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L, HERALD Study Group.
    Lancet Infect Dis; 2022 Mar 02; 22(3):329-340. PubMed ID: 34826381
    [Abstract] [Full Text] [Related]

  • 18. Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
    Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN).
    Lancet Oncol; 2011 Dec 02; 12(13):1195-203. PubMed ID: 21962393
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial.
    Park JK, Kim M, Jung JI, Kim JY, Jeong H, Park JW, Winthrop KL, Lee EB.
    Lancet Rheumatol; 2024 Jun 02; 6(6):e352-e360. PubMed ID: 38710192
    [Abstract] [Full Text] [Related]

  • 20. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM, Gomes Silva BN, Torloni MR, Soares BG.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD008858. PubMed ID: 23076951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.